Melbourne, Aug 8, 2008 (ABN Newswire) - Benitec Limited (ASX:BLT)(PINK:BNIKF) today announced that a key patent focused on producing Double-Stranded Nucleic Acid constructs for therapeutic and related applications of RNA interference (RNAi) was granted in New Zealand.
